www.businesstoday.in ·
Nifty Pharma Hits Fresh Record High Even as Market Slips Zydus Lifesciences Mankind Pharma Shares Among Top Gainers 532385 2026 05 20
Topic context
This topic has been covered 365634 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedThe Indian pharmaceutical sector is benefiting from a weak rupee (record low 96.88/USD), which boosts export revenues for companies like Zydus, Mankind, and Aurobindo. The Nifty Pharma index hit a record high despite a weak overall market, driven by strong earnings and currency tailwinds. The commercial mechanism is fx_passthrough: rupee depreciation directly improves margins for export-oriented pharma firms.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Nifty Pharma sub-index hit a record high on 2026-05-20.
- Zydus Lifesciences reported Q4 net profit up 8.7% YoY to Rs 1,272.5 crore.
- Zydus Lifesciences revenue up 16.2% YoY to Rs 7,587 crore.
- Indian rupee fell to a record low of 96.88 against USD.
- Zydus Lifesciences announced share buyback worth up to Rs 1,100 crore.
EM impact neutralized by pharma export strength and RBI intervention.
Sign in to see all sector verdicts, full thesis and counter-argument debate.
Sector impact at a glance
- EM_MARKETSmid
- EM_MARKETSshort
- FX_USDmid
- FX_USDshort
- PHARMA_BIOTECHmid
- PHARMA_BIOTECHshort
Related stories
finance.yahoo.com
Ncmi Q1 2026 Earnings Transcript
finance.yahoo.com
Transcript Valneva Q1 2026 Earnings
finance.yahoo.com
Aytu Aytu Q3 2026 Earnings
fool.com
Keysight Keys Q2 2026 Earnings Transcript
livemint.com